Aspire Private Capital LLC Decreases Holdings in Lam Research Corporation $LRCX

Aspire Private Capital LLC decreased its stake in Lam Research Corporation (NASDAQ:LRCX) by 35.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 10,792 shares of the semiconductor company’s stock after selling 5,850 shares during the period. Aspire Private Capital LLC’s holdings in Lam Research were worth $1,847,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. PMV Capital Advisers LLC bought a new stake in shares of Lam Research in the fourth quarter valued at $25,000. Stance Capital LLC purchased a new position in shares of Lam Research during the 3rd quarter valued at $26,000. Howard Hughes Medical Institute bought a new position in shares of Lam Research during the 2nd quarter worth $27,000. Triumph Capital Management purchased a new stake in Lam Research in the 3rd quarter worth about $27,000. Finally, Strategic Wealth Investment Group LLC purchased a new stake in Lam Research in the 2nd quarter worth about $29,000. 84.61% of the stock is currently owned by hedge funds and other institutional investors.

Lam Research News Roundup

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Q4 / recent results and demand signal continued strength — coverage notes that Lam’s Q4 showed robust revenue growth and margin expansion, supporting the view that AI-driven capex is lifting order activity. Strong Demand Lifted Lam Research Corporation (LRCX) in Q4
• Positive Sentiment: Analyst price-target bump — New Street raised its price target from $140 to $235 (while keeping a neutral rating), signaling more upside to consensus valuation assumptions and helping sentiment around the stock. New Street Adjusts Price Target on Lam Research
• Positive Sentiment: Industry AI tailwinds — sector pieces highlight broad AI-driven demand for memory and wafer fab equipment, which supports long-term secular growth for suppliers like Lam. Investors are treating Lam as a prime beneficiary of increased fab capex. Lam Research Corporation (LRCX): Billionaire Ray Dalio Trims Stake in Chip Stock
• Positive Sentiment: Bullish research/features — multiple pieces (Zacks, Seeking Alpha, MSN) reiterate Lam as a long-term pick given market position, improving operating metrics, and exposure to AI and foundry spending. Why Lam Research (LRCX) is a top stock for the long term
• Neutral Sentiment: Upcoming earnings call — Lam scheduled its March-quarter conference call for April 22; this will be the next formal catalyst where management can update demand visibility and guidance. Lam Research Announces March Quarter Financial Conference Call
• Neutral Sentiment: Company profile / coverage roundup — general profiles and previews are circulating; useful for context but less likely to move the stock absent new data. Lam Research Corporation — CNN Markets
• Negative Sentiment: Institutional trimming — Bridgewater/Ray Dalio’s fund trimmed a previously disclosed position, which can weigh on sentiment when a well-known investor reduces exposure. Lam Research Corporation (LRCX): Billionaire Ray Dalio Trims Stake in Chip Stock
• Negative Sentiment: Supply-chain risk — reporting on a possible Middle East-related helium shortage highlights a non-demand operational risk that could constrain equipment throughput or service for certain tools. Middle East Helium Shock Puts Lam Research Supply Chain In Focus

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on LRCX shares. Susquehanna set a $325.00 target price on shares of Lam Research and gave the stock a “positive” rating in a research note on Thursday, January 29th. TD Cowen upped their price target on shares of Lam Research from $170.00 to $290.00 and gave the company a “buy” rating in a research note on Thursday, January 29th. Oppenheimer reaffirmed an “outperform” rating and issued a $265.00 price objective on shares of Lam Research in a report on Thursday, January 29th. Mizuho set a $265.00 price objective on shares of Lam Research in a research note on Wednesday, January 28th. Finally, Argus boosted their target price on shares of Lam Research from $175.00 to $280.00 in a report on Tuesday, February 3rd. One investment analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat, Lam Research presently has a consensus rating of “Moderate Buy” and a consensus price target of $245.35.

Insider Buying and Selling

In other Lam Research news, insider Ava Harter sold 4,000 shares of Lam Research stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $232.50, for a total transaction of $930,000.00. Following the completion of the sale, the insider owned 54,705 shares of the company’s stock, valued at $12,718,912.50. The trade was a 6.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Douglas R. Bettinger sold 50,057 shares of the company’s stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $224.03, for a total value of $11,214,269.71. Following the completion of the transaction, the chief financial officer owned 1,081,705 shares of the company’s stock, valued at $242,334,371.15. The trade was a 4.42% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 130,886 shares of company stock worth $29,658,802. Corporate insiders own 0.31% of the company’s stock.

Lam Research Stock Performance

Lam Research stock opened at $222.01 on Thursday. Lam Research Corporation has a 1-year low of $56.32 and a 1-year high of $256.68. The company has a current ratio of 2.26, a quick ratio of 1.61 and a debt-to-equity ratio of 0.37. The firm has a market capitalization of $277.24 billion, a PE ratio of 45.49, a price-to-earnings-growth ratio of 2.30 and a beta of 1.78. The firm’s 50 day simple moving average is $227.05 and its 200 day simple moving average is $183.95.

Lam Research (NASDAQ:LRCX) last released its quarterly earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 EPS for the quarter, beating analysts’ consensus estimates of $1.17 by $0.10. The firm had revenue of $5.34 billion during the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The business’s revenue for the quarter was up 22.1% on a year-over-year basis. During the same period in the previous year, the business earned $0.91 EPS. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. As a group, analysts expect that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 8th. Stockholders of record on Wednesday, March 4th will be issued a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend is Wednesday, March 4th. Lam Research’s payout ratio is currently 21.31%.

Lam Research Company Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.